Cargando…

Novel Therapeutic Targets in Melanoma

Detalles Bibliográficos
Autores principales:	Cerezo, Michaël, Rocchi, Stéphane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913784/ https://www.ncbi.nlm.nih.gov/pubmed/36765705 http://dx.doi.org/10.3390/cancers15030747

Ejemplares similares

Targeting BIP to induce Endoplasmic Reticulum stress and cancer cell death
por: Cerezo, Michaël, et al.
Publicado: (2016)

Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma
por: Pietrobono, Silvia, et al.
Publicado: (2023)

Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy
por: Cerezo, Michaël, et al.
Publicado: (2020)

Novel Biomarkers and Therapeutic Targets for Melanoma
por: Sabag, Noa, et al.
Publicado: (2022)

Novel Therapeutic Targets in Cancers
por: Levantini, Elena
Publicado: (2023)

Metformin: Focus on Melanoma
por: Jaune, Emilie, et al.
Publicado: (2018)

Novel therapeutic target against Alzheimer
por: LeBlanc, Andrea C.
Publicado: (2017)

Targeted Therapies for Melanoma
por: Smetana, Karel, et al.
Publicado: (2020)

Novel Targets and Therapeutic Strategies for Promoting Organ Repair and Regeneration
por: Muruganandan, Shanmugam, et al.
Publicado: (2020)

Novel Therapeutic Targets for Tumor Microenvironment in Cancer
por: Bei, Roberto, et al.
Publicado: (2023)

HLX in AML: novel prognostic and therapeutic target
por: Pandolfi, Ashley, et al.
Publicado: (2012)

NECTIN4: A Novel Therapeutic Target for Melanoma
por: Tanaka, Yuka, et al.
Publicado: (2021)

Novel Oncology Therapeutics: Targeted Drug Delivery for Cancer
por: Tzakos, Andreas G., et al.
Publicado: (2013)

Neurovascular unit protection—novel therapeutic targets and strategies
por: Chen, Chen, et al.
Publicado: (2021)

Targeted therapeutics in melanoma
por: Ali, Z, et al.
Publicado: (2012)

Pathways and therapeutic targets in melanoma
por: Shtivelman, Emma, et al.
Publicado: (2014)

Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype
por: Ohanna, Mickaël, et al.
Publicado: (2018)

Novel Therapeutic Targets in Metabolic Disorders: From the Bench to the Bedside
por: Illario, Maddalena, et al.
Publicado: (2014)

Lymphatic Dysfunction as a Novel Therapeutic Target in Nonalcoholic Steatohepatitis
por: Jeong, Jain, et al.
Publicado: (2020)

Metastatic melanoma and vemurafenib: novel approaches
por: De Mello, Ramon Andrade
Publicado: (2012)

Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies
por: Jaune, Emilie, et al.
Publicado: (2021)

Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment
por: Pardella, Elisa, et al.
Publicado: (2020)

Gp-100 as a Novel Therapeutic Target in Uveal Melanoma
por: Martinez-Perez, Daniel, et al.
Publicado: (2021)

Targeted treatment of advanced NRAS-mutated melanoma
por: Koelblinger, Peter, et al.
Publicado: (2017)

Targeting melanoma residual disease by USP7
por: Vishnoi, Monika, et al.
Publicado: (2018)

STAT5b in LGL leukemia – a novel therapeutic target?
por: Rajala, Hanna L. M., et al.
Publicado: (2013)

Novel treatment paradigms for metastatic uveal melanoma
por: Patel, Sapna P., et al.
Publicado: (2022)

Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib
por: Lehraiki, Abdelali, et al.
Publicado: (2015)

Advances in Systemic Sclerosis: From Pathogenetic Pathways toward Novel Therapeutic Targets
por: Romano, Eloisa, et al.
Publicado: (2023)

Semaphorin 4A as novel regulator and promising therapeutic target in rheumatoid arthritis
por: Chapoval, Svetlana P.
Publicado: (2015)

The ubiquitin-activating enzyme, UBA1, as a novel therapeutic target for AML
por: Barghout, Samir H., et al.
Publicado: (2018)

Novel paradigms of macrophage biology and function: identification of disease biomarkers and therapeutic targets
por: Wang, Diane Catherine, et al.
Publicado: (2022)

SHP2 phosphatase as a novel therapeutic target for melanoma treatment
por: Zhang, Ruo-Yu, et al.
Publicado: (2016)

Pin1–FOXM1 inhibitors: a potential therapeutic for metastatic melanoma?
por: de Keizer, Peter LJ
Publicado: (2016)

The TWEAK Receptor Fn14 is a Novel Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment
por: Zhou, Hong, et al.
Publicado: (2012)

Oxidative Stress and Inflammation as Targets for Novel Preventive and Therapeutic Approches in Non Communicable Diseases
por: Nediani, Chiara, et al.
Publicado: (2020)

HNRNPM Regulates HCC Tumorigenesis and Cancer Stemness: Identification of a Novel Therapeutic Target?
por: Kennedy, Lindsey
Publicado: (2022)

Targeting ferroptosis in melanoma: cancer therapeutics
por: Khorsandi, Khatereh, et al.
Publicado: (2023)

NUMB as a Therapeutic Target for Melanoma
por: Hristova, Denitsa M., et al.
Publicado: (2022)

EGFR and mTOR as therapeutic targets in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cd54libasj1tj4dkd8vf5c84vv